FindTrial
Sign In

Clinical Outcomes of Treatment in Pediatric Medulloblastoma Based on Molecular Subgroup: A Single-center Experience.

Clinical Outcomes of Treatment in Pediatric Medulloblastoma Based on Molecular Subgroup: A Single-center Experience.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20200825004
Enrollment
60
Registered
2020-08-25
Start date
2020-08-30
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medulloblastoma Medulloblastoma Molecular Subgroup overall survival

Interventions

Pediatric medulloblastoma patients treated at King Chulalongkorn memorial hospital from 2008 till 2019
Treatment
Pediatric Medulloblastoma

Sponsors

Ratchadapiseksompotch Fund,Faculty of Medicine, Chulalongkorn university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 15 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed medulloblastoma with pathological confirmation. 2. Aged < 15 years old 3. Treated with surgery followed by craniospinal irradiation.

Exclusion criteria

Exclusion criteria: 1. Incomplete medical records and radiotherapy treatment data. 2. Incomplete treatment 3. Other malignancy before diagnosis which can interfere the treatment outcome

Design outcomes

Primary

MeasureTime frame
Overall survival 5 year Kaplan&#45;Meier method&#44; log rank test—

Secondary

MeasureTime frame
Event free survival 5 year Kaplan&#45;Meier method&#44; log rank test—

Countries

Thailand

Contacts

Public ContactKanjana Shotelersuk

Division of Radiation Oncology&#44; Radiology department&#44; Faculty of Medicine&#44; Chulalongkorn University

kanjanash@yahoo.co.th022564334

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026